Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | BLM | P54132 | 2/20 | 0.52 |
| ▸ | RECQL | P46063 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | F2 | P00734 | 1/20 | 0.52 |
| ▸ | F10 | P00742 | 1/20 | 0.52 |
| ▸ | F12 | P00748 | 1/20 | 0.52 |
| ▸ | F7 | P08709 | 1/20 | 0.52 |
| ▸ | F3 | P13726 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | PARP1 | P09874 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1282296 | 0.87 | BLM (0.58) | TSHRBLMRECQLCYP2C19POLB | |
| SCHEMBL1766180 | 0.87 | BLM (0.58) | TSHRBLMRECQLCYP2C19POLB | |
| SCHEMBL38341 | 0.87 | BLM (0.58) | TSHRBLMRECQLCYP2C19POLB | |
| SCHEMBL1774314 | 0.84 | BLM (0.55) | TSHRBLMRECQLCYP2C19POLB | |
| Hydrochloric Acid SCHEMBL4620960 | 0.84 | BLM (0.60) | TSHRBLMRECQLCYP2C19POLB | |
| SCHEMBL30465109 | 0.84 | BLM (0.55) | TSHRBLMRECQLCYP2C19POLB | |
| SCHEMBL22142638 | 0.79 | TSHR (0.50) | TSHRBLMRECQLCYP2C19POLB | |
| SCHEMBL12262965 | 0.77 | BLM (0.48) | TSHRBLMRECQLCYP2C19POLB | |
| SCHEMBL9250790 | 0.77 | BLM (0.48) | TSHRBLMRECQLCYP2C19POLB | |
| SCHEMBL140664 | 0.77 | BLM (0.48) | TSHRBLMRECQLCYP2C19POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111683942-B | Compound, organic light-emitting device and display device | SK 株式会社 | 2024-10-25 | — | — | CN | disclosed |
| CN-117980369-A | Polymer and organic light emitting device using the same | 株式会社LG化学 | 2024-05-03 | — | — | CN | disclosed |
| CN-117751153-A | Polymer and organic light-emitting element using same | 株式会社LG化学 | 2024-03-22 | — | — | CN | disclosed |
| CN-117715953-A | Polymer and organic light emitting device using the same | 株式会社LG化学 | 2024-03-15 | — | — | CN | disclosed |
| CN-117603238-A | Boron-nitrogen atom-containing heterocyclic compound and application thereof | 浙江八亿时空先进材料有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-117586288-A | Carbazole derivative and application thereof | 浙江八亿时空先进材料有限公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-114761462-B | Polymer and organic light emitting diode using the same | 株式会社LG化学 | 2024-02-23 | — | — | CN | disclosed |
| CN-113166165-B | Heterocyclic compound and organic light-emitting diode comprising same | 株式会社LG化学 | 2023-11-24 | — | — | CN | disclosed |
| CN-116964125-A | Polymer and organic light emitting device using the same | 株式会社LG化学 | 2023-10-27 | — | — | CN | disclosed |
| CN-111684615-B | Organic light emitting device | 株式会社LG化学 | 2023-10-17 | — | — | CN | disclosed |
| US-6995175-B2 | Chemical derivatives and their application as antitelomerase agent | AVENTIS PHARMA S.A. (FR) | 2006-02-07 | — | — | US | disclosed |
| US-20060014792-A1 | Heterocyclo inhibitors of potassium channel function | LLOYD JOHN | 2006-01-19 | — | — | US | disclosed |
| CN-1714077-A | 2-, 3-, 4-or 5-substituted N1- (phenylsulfonyl) indoles and their therapeutic use | BIOVITRUM AB (SE) | 2005-12-28 | — | — | CN | disclosed |
| EP-1451173-A4 | PIPERIDINES | ICAGEN INC (US) | 2005-10-26 | — | — | EP | disclosed |
| CN-1585757-A | Oligopeptides and compositions containing them as cathepsin S inhibitors | AVENTIS PHARMA INC (US) | 2005-02-23 | — | — | CN | disclosed |
| EP-1451173-A2 | PIPERIDINES | Icagen, Inc. (US) | 2004-09-01 | — | — | EP | disclosed |
| US-20040138257-A1 | Chemical derivatives and their application as antitelomerase agent | AVENTIS PHARMA S.A. (FR) | 2004-07-15 | — | — | US | disclosed |
| US-20040110793-A1 | Heterocyclo inhibitors of potassium channel function | BRISTOL-MYERS SQUIBB COMPANY | 2004-06-10 | — | — | US | disclosed |
| US-20030171360-A1 | Piperidines | ICAGEN, INC. | 2003-09-11 | — | — | US | disclosed |
| WO-2003037890-A2 | PIPERIDINES | ICAGEN, INC. (US) | 2003-05-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040138257-A1 | Chemical derivatives and their application as antitelomerase agent | NTPCR, DPYD, NME1 | TSHR 3754/4885BLM 2212/4885RECQL 2266/4885 |
| US-20060014792-A1 | Heterocyclo inhibitors of potassium channel function | KCNJ2, KCNH2, KCNQ5 | TSHR 2555/4885BLM 1382/4885RECQL 1358/4885 |
| US-20030171360-A1 | Piperidines | TRPV3, SCN3A, TRPV1 | TSHR 4322/4885BLM 4565/4885RECQL 3574/4885 |
| US-20040110793-A1 | Heterocyclo inhibitors of potassium channel function | KCNH2, KCNN1, KCNJ2 | TSHR 4215/4885BLM 1524/4885RECQL 1052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.